BioHealth News

Emergent and Rocketvax Partner on Next-Gen Product Development

Emergent and Rocketvax Partner on Next-Gen Product Development

GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across…

Read More
Rockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted

Rockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted

Rockville, Md. (March 11, 2025) – Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic, platelet-derived, cellular therapeutics, is excited to announce…

Read More
IonQ Raises Over $372 Million Via At-the-Market Equity Offering Program

IonQ Raises Over $372 Million Via At-the-Market Equity Offering Program

COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ, Inc. (NYSE: IONQ), a leader in the quantum computing and quantum networking industries, today announced that under its “at-the-market” equity…

Read More
Syngene Acquires its First Manufacturing Facility in Baltimore

Syngene Acquires its First Manufacturing Facility in Baltimore

BANGALORE, India, March 10, 2025 /PRNewswire/ -- Syngene International Limited ('Syngene'), a global contract research, development, and manufacturing organization (CRDMO), today announced the acquisition of its…

Read More
MCCC Trends in Life Science Event: Exploring Industry Shifts, Regulations, and Growth Opportunities – Rich Bendis Keynote Speaker

MCCC Trends in Life Science Event: Exploring Industry Shifts, Regulations, and Growth Opportunities – Rich Bendis Keynote Speaker

The life sciences industry is constantly evolving, influenced by new technologies, regulatory changes, and market dynamics. To help professionals stay informed, the MCCC Life…

Read More
Altimmune to Host Virtual R&D Day on March 13, 2025

Altimmune to Host Virtual R&D Day on March 13, 2025

GAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will host a virtual R&D…

Read More
WBJ: New York health-tech company Claritev moves headquarters to Northern Virginia

WBJ: New York health-tech company Claritev moves headquarters to Northern Virginia

By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 5, 2025 - A New York health care technology company that recently adopted a…

Read More
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared…

Read More
Ascentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)

Ascentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)

ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering,…

Read More
USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients

USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients

USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients  Rockville, MD – The U.S. Pharmacopeia (USP)…

Read More
TEDCO Invests in Irazú Oncology

TEDCO Invests in Irazú Oncology

Life sciences company developing a cost-effective production process for cancer immunotherapies COLUMBIA, Md., (March 5, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a…

Read More
REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases

REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases

ROCKVILLE, Md., March 4, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the closing of its previously announced strategic partnership with Nippon Shinyaku. Under the terms of the…

Read More
IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection

POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced an advancement in its Artificial Intelligence…

Read More
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication expansion for its industry leading…

Read More
Venture Valkyrie: Tough Love for Women’s Health Entrepreneurs Raising Venture Money

Venture Valkyrie: Tough Love for Women’s Health Entrepreneurs Raising Venture Money

Since I have been raising and deploying a venture fund focused on addressing health of women lately, I have had numerous occasions to be in rooms…

Read More